Multi-omics to Predict Responses to Biologics in IBD

NCT05542459 · clinicaltrials.gov ↗

UNKNOWN

Status

1050

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Ulcerative Colitis

Interventions

DRUG: Biologics

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University